<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320783">
  <stage>Registered</stage>
  <submitdate>4/11/2009</submitdate>
  <approvaldate>6/11/2009</approvaldate>
  <actrnumber>ACTRN12609000959279</actrnumber>
  <trial_identification>
    <studytitle>Virtual Reality Exposure Therapy for Agoraphobia</studytitle>
    <scientifictitle>Virtual Reality Exposure Therapy for Agoraphobia involving a cognitive component: a comparative trial</scientifictitle>
    <utrn>U1111-1112-3836</utrn>
    <trialacronym>VR Agora</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Agoraphobia</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Anxiety</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment of agoraphobia by using virtual reality exposure and cognitive therapy. Virtual reality exposure involves the confrontation of the agoraphobics with 3D real time computerized phobogenic situations. Cognitive therapy implies the use of cognitive therapy techniques (cognitive restructuring). Both are administered by a PhD student in clinical psychology.
  Protocol :
1 weekly session of 1 and a half hour for 2 and a half month (total 10 sessions : 2 of cognitive and 8 of virtual reality exposure)</interventions>
    <comparator>Virtual reality exposure therapy alone. 
Protocol :
1 weekly session of 1 and a half hour for 2 and a half month (total 10 sessions : 2 of neutral conversation and 8 of virtual reality exposure).</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Anxiety Sensitivity Index ASI (Peterson 1993). This instrument is a 16-item questionnaire which rate the fear of anxiety-related symptoms</outcome>
      <timepoint>At Baseline, after last therapeutic session and 6 months Follow Up</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Agoraphobia cognitions questionnaire ACQ (Chambless 1984) is 5 points scale questionnaires comprising 14 items to rate the intensity of thoughts regarding agoraphobia cognitions.</outcome>
      <timepoint>At Baseline, after last therapeutic session and 6 months Follow Up</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Mobility inventory for agoraphobia MIA, part 1 (Chambless 1985).  This a 5 point Likert scale rating the severity of behavioural avoidance of situations dreaded by the agoraphobics</outcome>
      <timepoint>At Baseline, after last therapeutic session and 6 months Follow Up</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Behavioral Avoidance Test BAT. Classic objective behavioural measures of phobia intensity and clinical progress.</outcome>
      <timepoint>At Baseline, after last therapeutic session and 6 months Follow Up</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Depression Anxiety Stress Scales DASS 21 (Lovibond 1995) is a 21-items subjective questionnaire that uses a 4 point scale to measure mood and depressive symptoms, anxiety and stress</outcome>
      <timepoint>At Baseline, after last therapeutic session and 6 months Follow Up</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of Agoraphobia with or without Panic disorder</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>pregnancy, epilepsy, severe organic condition, Heart arrhythmia, vestibular syndrome, substance abuse, discontinuation in the psychiatric treatment, psychosis (schizoid or not schizoid) and absence of competence in use of English</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants will be recruited through different and various means.Diagnosis procedure will involve experienced post graduate psychology students under the supervision of a Clinic Director. Following the diagnosis, Allocation concealment will be achieved by using sealed opaque envelopes addressed to the researchers.</concealment>
    <sequence>Each participants will be characterized by a specific number and this code will be feed in  a randomization table created by a computer software</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>35</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2109</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Macquarie University (Psychology Dpt)</primarysponsorname>
    <primarysponsoraddress>Psychology department
Macquarie University
North Ryde
NSW 2109
Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Macquarie University</fundingname>
      <fundingaddress>Macquarie University
North Ryde
NSW 2109
Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Agoraphobia, a quite common anxiety disorder in Australia, is defined as the fear of being in places or situations from which escape might be difficult or embarrassing. Standard exposure therapy is not bereft of weaknesses. Hence, new research lines study the virtual reality exposure therapy. Virtual reality allows patients to interact in real time 3D computerized worlds. The project will include a sample of volunteered patients suffering from agoraphobia who will be exposed to virtual environments specifically created for the present study using an affordable game editor. This collaborative efforts goal is finally to search for a better understanding of agoraphobia innovative treatment and to discover presence objective measure instruments.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Macquarie University Ethics Review Committee</ethicname>
      <ethicaddress>Macquarie University Ethics Review Committee 
Research Office
 Level 3, Research HUB, Building C5C, Macquarie University, NSW 2109.</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>20/11/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Eric Malbos</name>
      <address>Dept. of Psychology, Building C3A, Room 709
Macquarie University, Sydney, NSW 2109, Australia.</address>
      <phone>+61 2 9850 8053</phone>
      <fax>+61 2 9850 8062</fax>
      <email>Eric.Malbos@psy.mq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Eric Malbos</name>
      <address>Dept. of Psychology, Building C3A, Room 709
Macquarie University, Sydney, NSW 2109, Australia.</address>
      <phone>+61 2 9850 8053</phone>
      <fax>+61 2 9850 8062</fax>
      <email>Eric.Malbos@psy.mq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Eric Malbos</name>
      <address>Dept. of Psychology, Building C3A, Room 709
Macquarie University, Sydney, NSW 2109, Australia.</address>
      <phone>+61 2 9850 8053</phone>
      <fax>+61 2 9850 8062</fax>
      <email>Eric.Malbos@psy.mq.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>